COMPANY
Medosome Biotec
Funding and NIH signals
- NIH award NIH awarded $356K (SBIR Phase I 1R43DK146558-01, new, notice Jul 14, 2026). NIH RePORTER 1R43DK146558-01 (Jul 14, 2026)
Evidence (1 event)
- Jul 14, 2026 · NIH RePORTER 1R43DK146558-01
Organization: MEDOSOME BIOTEC, LLC; City/State: Alachua, FL; Project number: 1R43DK146558-01; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-07-14; FY total cost (award amount): 356251; Administering IC: National Institute of Diabetes and Digestive and Kidney Diseases; Project title: Developing GLP-1 Producing Genetically Engineered Probiotics for Treatment of Metabolic Diseases; Organization type: Domestic For-Profits
- Jul 14, 2026 · NIH RePORTER 1R43DK146558-01
Timeline
- Grant Government grant — SBIR: $356,251 (annual award, as published), announced Jul 14, 2026. Agency: NIH/NIDDK. Source: government award database. source ↗
Funding
- Government grant — SBIR: $356,251 (annual award, as published), announced Jul 14, 2026. Agency: NIH/NIDDK. Source: government award database. source ↗
NIH awards 24
- NIH award 1R42GM151928-01A1 FY2024: $350,000 awarded for that fiscal year; activity R42 (STTR); PI ALAM, HASAN B; recipient as written: MEDOSOME BIOTEC, LLC, Alachua, FL. Metabolism and Mitochondrial Energetics Thera source ↗
- NIH award 1R43TR004525-01 FY2023: $325,000 awarded for that fiscal year; activity R43 (SBIR); PI WAGNER, RICHARD; recipient as written: MEDOSOME BIOTEC, LLC, Alachua, FL. Engineering next generation probiotics for de source ↗
- NIH award 5R42AI122855-03 FY2023: $1,000,000 awarded for that fiscal year; activity R42 (STTR); PI WANG, GARY P.; recipient as written: MEDOSOME BIOTEC, LLC, Alachua, FL. A method for accurate and sensitive detection source ↗
- NIH award 2R42AI122855-02A1 FY2022: $999,999 awarded for that fiscal year; activity R42 (STTR); PI WANG, GARY P.; recipient as written: MEDOSOME BIOTEC, LLC, Alachua, FL. A method for accurate and sensitive detection source ↗
- NIH award 5R42HD089804-06 FY2022: $985,330 awarded for that fiscal year; activity R42 (STTR); PI STACPOOLE, PETER WALLACE; recipient as written: MEDOSOME BIOTEC, LLC, Alachua, FL. Personalized dosing of dichloroaceta source ↗
- NIH award 5R44DK112540-03 FY2022: $776,646 awarded for that fiscal year; activity R44 (SBIR); PI WAGNER, RICHARD; recipient as written: MEDOSOME BIOTEC, LLC, Alachua, FL. Next generation quantitative HCV drug resista source ↗
- NIH award 5R42HD089804-05 FY2021: $992,757 awarded for that fiscal year; activity R42 (STTR); PI STACPOOLE, PETER WALLACE; recipient as written: MEDOSOME BIOTEC, LLC, Alachua, FL. Personalized dosing of dichloroaceta source ↗
- NIH award 2R44DK112540-02 FY2021: $834,451 awarded for that fiscal year; activity R44 (SBIR); PI WAGNER, RICHARD; recipient as written: MEDOSOME BIOTEC, LLC, Alachua, FL. Next generation quantitative HCV drug resista source ↗
- NIH award 5R42HD097911-03 FY2021: $700,593 awarded for that fiscal year; activity R42 (STTR); PI WAGNER, RICHARD; recipient as written: MEDOSOME BIOTEC, LLC, Alachua, FL. Prevention of White Matter Injury in Prematur source ↗
- NIH award 2R42HD089804-04 FY2020: $1,000,000 awarded for that fiscal year; activity R42 (STTR); PI STACPOOLE, PETER WALLACE; recipient as written: MEDOSOME BIOTEC, LLC, Alachua, FL. Personalized dosing of dichloroace source ↗
- NIH award 4R42HD097911-02 FY2020: $993,274 awarded for that fiscal year; activity R42 (STTR); PI RIVKEES, SCOTT A.; recipient as written: MEDOSOME BIOTEC, LLC, Alachua, FL. Prevention of White Matter Injury in Premat source ↗
- NIH award 1R41DK123953-01 FY2019: $225,000 awarded for that fiscal year; activity R41 (STTR); PI RIVKEES, SCOTT A.; recipient as written: MEDOSOME BIOTEC, LLC, Alachua, FL. Development of a Novel Therapeutic for Hype source ↗
- NIH award 1R43HL149554-01 FY2019: $225,000 awarded for that fiscal year; activity R43 (SBIR); PI WAGNER, RICHARD; recipient as written: MEDOSOME BIOTEC, LLC, Alachua, FL. Optimization of recombinant probiotics for or source ↗
- NIH award 1R42HD097911-01A1 FY2019: $223,899 awarded for that fiscal year; activity R42 (STTR); PI RIVKEES, SCOTT A.; recipient as written: MEDOSOME BIOTEC, LLC, Alachua, FL. Prevention of White Matter Injury in Prem source ↗
- NIH award 5R42HD089804-03 FY2018: $695,065 awarded for that fiscal year; activity R42 (STTR); PI STACPOOLE, PETER WALLACE; recipient as written: MEDOSOME BIOTEC, LLC, Alachua, FL. Personalized dosing of dichloroaceta source ↗
- NIH award 4R42HD089804-02 FY2017: $793,897 awarded for that fiscal year; activity R42 (STTR); PI STACPOOLE, PETER WALLACE; recipient as written: MEDOSOME BIOTEC, LLC, Alachua, FL. Personalized dosing of dichloroaceta source ↗
- NIH award 1R43DK112540-01A1 FY2017: $232,433 awarded for that fiscal year; activity R43 (SBIR); PI WAGNER, RICHARD; recipient as written: MEDOSOME BIOTEC, LLC, Alachua, FL. Next generation quantitative HCV drug resis source ↗
- NIH award 1R41HD092133-01 FY2017: $223,899 awarded for that fiscal year; activity R41 (STTR); PI CHENG, SAM X; recipient as written: MEDOSOME BIOTEC, LLC, Alachua, FL. Development of CaSR nutrient therapy for childho source ↗
- NIH award 1R42HD089804-01 FY2016: $224,978 awarded for that fiscal year; activity R42 (STTR); PI STACPOOLE, PETER WALLACE; recipient as written: MEDOSOME BIOTEC, LLC, Alachua, FL. Personalized dosing of dichloroaceta source ↗
- NIH award 1R41AI122735-01 FY2016: $294,094 awarded for that fiscal year; activity R41 (STTR); PI SRIVASTAVA, ARUN; recipient as written: MEDOSOME BIOTEC, LLC, Alachua, FL. Development of Optimized AAV Serotype Vector source ↗
- NIH award 1R41AR068158-01A1 FY2016: $224,463 awarded for that fiscal year; activity R41 (STTR); PI KANG, PETER B.; recipient as written: MEDOSOME BIOTEC, LLC, Alachua, FL. Novel therapies for inherited muscle disease source ↗
- NIH award 1R41AI122855-01A1 FY2016: $253,244 awarded for that fiscal year; activity R41 (STTR); PI WANG, GARY P.; recipient as written: MEDOSOME BIOTEC, LLC, Alachua, FL. A method for accurate and sensitive detection source ↗
- NIH award 1R41NS095475-01 FY2015: $217,801 awarded for that fiscal year; activity R41 (STTR); PI RIVKEES, SCOTT A.; recipient as written: MEDOSOME BIOTEC, LLC, Alachua, FL. Discovery of Oligodendrocyte Stimulators source ↗
- NIH award 1R43FD005349-01 FY2015: $122,439 awarded for that fiscal year; activity R43 (SBIR); PI WAGNER, RICHARD; recipient as written: MEDOSOME BIOTEC, LLC, Alachua, FL. Rapid Haplotyping procedure for determining t source ↗